CUREBOUND

CUREBOUND LEADS WITH A TRULY UNIQUE INVESTMENT MODEL FOCUSED ON CROSS INSTITUTIONAL COLLABORATION. THIS APPROACH BRINGS TOGETHER IDEAS, TECHNOLOGIES, AND RESEARCH APPROACHES THAT SIMPLY CANNOT OCCUR WITHIN ONE INSTITUTION AND ULTIMATELY ACCELERATES DISCOVERIES TO CLINICAL APPLICATION TO SAVE LIVES. THE RESEARCH TEAM FUNDED REPRESENT THE THREE NCI CANCER CENTERS IN SAN DIEGO WITH MOORES CANCER CENTER AT UC SAN DIEGO HEALTH, THE SALK INSTITUTE, AND SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE. ALSO, RADY CHILDREN'S HOSPITAL, SCRIPPS RESEARCH, AND THE LA JOLLA INSTITUTE OF IMMUNOLOGY. WE ESTABLISHED THE CANCER RESEARCH PROGRAM TO FUND THE MOST PROMISING, INNOVATIVE ONCOLOGY RESEARCH ACROSS ALL CANCER TYPES IN ALIGNMENT WITH FIVE SCIENTIFIC INVESTMENT PILLARS PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITES, AND PEDIATRIC CANCERS. THIS YEAR ALONE, OVER TWO MILLION PEOPLE WILL BE DIAGNOSED WITH CANCER, AND IT IS THE NUMBER TWO CAUSE OF DEATH IN THE UNITED STATES. OUR MISSION IS TO MOBILIZE SAN DIEGO TO ACCELERATE CURES FOR CANCER IN OUR LIFETIME. AND THE VISION OF CUREBOUND IS A WORLD WITHOUT CANCER. CUREBOUND IS HEADQUARTERED IN SAN DIEGO AMIDST A UNIQUE COMBINATION OF THREE NCI CANCER CENTERS, CLINICAL CARE HOSPITALS, BIOTECH COMPANIES, VENTURE CAPITAL INVESTORS, PHILANTHROPIC NETWORKS, AND MOST IMPORTANTLY- A REGIONAL CULTURE THAT EMBRACES THE SPIRIT OF COLLABORATION. THIS ECOSYSTEM POSITIONS SAN DIEGO AND CUREBOUND AT THE FOREFRONT OF DISCOVERY BRINGING GENOMIC MEDICINE, NEW TECHNOLOGIES AND CLINICAL TRIALS TO MARKET AND PRESENTS AN UNPRECEDENTED OPPORTUNITY FOR RESEARCH COLLABORATION. WE BELIEVE THAT THE NEXT DECADE WILL BE CRITICAL TO THE DEVELOPMENT OF SOPHISTICATED, PERSONALIZED APPROACHES IN THE WAY WE PREVENT, TREAT, AND ULTIMATELY FIND CURES FOR CANCER.